Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-049605

Chairman and CEO bought 1,950 shares at an average $1.37 ($2,665)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-09-02 Purchase +650 $1.44 $936 10,679,646 D
Niihara Yutaka Chairman and CEO 2020-09-03 Purchase +1,300 $1.33 $1,729 10,680,946 D
Open-market purchases · 1,950 sh · avg $1.37 · $2,665
Loading xslF345X03/doc4.xml…